Delta-Fly Pharma Overview
- Year Founded
-
2010
- Status
-
Public
- Employees
-
12
- Stock Symbol
-
4598
- Share Price
-
$0.36
- (As of Tuesday Closing)
Delta-Fly Pharma General Information
Description
Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.
Contact Information
Website
www.delta-flypharma.co.jpCorporate Office
- 37-5 Nishikino, Miyajima
- Kawauchi-cho
- Tokushima, Tokushima Prefecture 771-0116
- Japan
Corporate Office
- 37-5 Nishikino, Miyajima
- Kawauchi-cho
- Tokushima, Tokushima Prefecture 771-0116
- Japan
Delta-Fly Pharma Stock Performance
As of 17-Nov-2026, Delta-Fly Pharma’s stock price is $0.36. Its current market cap is $5.17M with 14.2M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.36 | $0.36 | $0.34 - $4.46 | $5.17M | 14.2M | 1.43M | -$0.93 |
Delta-Fly Pharma Financials Summary
As of 31-Mar-2026, Delta-Fly Pharma has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Mar-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 12,109 | 12,109 | 32,287 | 34,069 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (10,768) | (10,768) | (11,262) | (9,865) |
| Net Income | (10,788) | (10,788) | (11,286) | (9,893) |
| Total Assets | 1,543 | 1,543 | 2,902 | 9,740 |
| Total Debt | 0 | 0 | 0 | 0 |
Delta-Fly Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Delta-Fly Pharma Patents
Delta-Fly Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026203214-A1 | Pharmaceutical preparation stable over long period of time | Pending | 27-Mar-2025 | ||
| JP-2025187628-A | Treatment for terminal pancreatic cancer | Pending | 14-Jun-2024 | ||
| US-11684582-B2 | Method for stabilizing humidity-sensitive pharmaceutical substance and stabilized preparation thereof | Active | 31-Mar-2021 | ||
| US-20220313613-A1 | Method for stabilizing humidity-sensitive pharmaceutical substance and stabilized preparation thereof | Active | 31-Mar-2021 | ||
| EP-4091614-B1 | Method for stabilizing medicinal substance sensitive to humidity (dfp-11207), and stable preparation thereof | Active | 31-Mar-2021 | A61K31/513 |
Delta-Fly Pharma Signals
Delta-Fly Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Delta-Fly Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Delta-Fly Pharma FAQs
-
When was Delta-Fly Pharma founded?
Delta-Fly Pharma was founded in 2010.
-
Where is Delta-Fly Pharma headquartered?
Delta-Fly Pharma is headquartered in Tokushima, Japan.
-
What is the size of Delta-Fly Pharma?
Delta-Fly Pharma has 12 total employees.
-
What industry is Delta-Fly Pharma in?
Delta-Fly Pharma’s primary industry is Drug Discovery.
-
Is Delta-Fly Pharma a private or public company?
Delta-Fly Pharma is a Public company.
-
What is Delta-Fly Pharma’s stock symbol?
The ticker symbol for Delta-Fly Pharma is 4598.
-
What is the current stock price of Delta-Fly Pharma?
As of 17-Nov-2026 the stock price of Delta-Fly Pharma is $0.36.
-
What is the current market cap of Delta-Fly Pharma?
The current market capitalization of Delta-Fly Pharma is $5.17M.
-
What is Delta-Fly Pharma’s annual earnings per share (EPS)?
Delta-Fly Pharma’s EPS for 12 months was -$0.93.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process